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From single-molecule sensing to characterization of extracellular 
vesicles in glioma cells under stress 
 
Virginia Claudio 
Department of Applied Physics 
Chalmers University of Technology 
 
Abstract 
This thesis describes the work I conducted in two different areas, namely biomolecular 
sensing and quantitative cell biology. The work in the former area was focused on the 
optimization of plasmonic metamaterials for sensing applications, and in the latter on the 
characterization of extracellular vesicles released by glioblastoma cells under stress 
conditions. If these two areas appear to be very far apart, it is because they are; however, they 
are not entirely disconnected. Understanding the biological function of extracellular vesicles 
depends on the information that can be obtained using bioanalytical sensors, which 
consequently relates to the information that can be gained from cellular experiments. 
Attempts were therefore made to review and exploit biophysical approaches that link the two 
areas, with focus on how detailed insights about the nature of these vesicles relate to their 
biological function. 
At its core, this thesis deals with: i) plasmonic biomolecular sensing, discussing noise-
related issues, single-molecule detection and a dual-wavelength method to extract more – and 
more accurate – information from ensemble measurements of complex macromolecular 
entities, including extracellular vesicles; ii) an introduction to glioblastomas, cellular models 
of hypoxic and oxidative stress, the role of extracellular vesicles in cellular communication in 
cancer, and an exploratory omics approach to understand how the biochemical composition of 
cells and vesicles changes across different cell lines in response to stress. As an encompassing 
bridge, a review on the techniques used to characterize extracellular vesicles also acts as an 
integrating element of this thesis and will help the reader understand different aspects of 
relevance with respect to how the physical and biological viewpoints intersect. 
The main findings of the work on biomolecular sensing consist in: i) the clarification of the 
interplay between inhomogeneous binding probability to a nanosensor (which depends on 
diffusion/geometry) and the inhomogeneous sensitivity distribution of the nanosensor itself as 
combined sources of detection uncertainty and ii) a method exploiting dual-wavelength 
plasmonic sensing to estimate the degree of deformation of adsorbed extracellular vesicles 
and hence more accurate determination of their mean size and bulk concentration. In the 
second area we find that iii) the proteome of vesicles mainly depends on cell type of origin 
and is greatly affected by stress, although in a heterogeneous way, with respect to the cells 
proteome; on the contrary, iv) the lipid composition of extracellular vesicles is very stable 
across cell types and stress. 
 
Keywords: single molecule sensing, surface plasmon resonance, nanoplasmonics, 
extracellular vesicles, exosomes, cellular stress, glioblastoma, proteome, lipid composition. 
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Chapter 1 
Introduction 
In 2001 the National Institute of Health released a detailed program announcement 
encouraging basic research on the detection and manipulation of single molecules [1]. This 
and other ongoing large scale efforts are motivated by the limitations associated with 
ensemble experiments where details on the molecular properties are lost in the averaging. 
Moreover, reaction dynamics are hard to determine when the concentration of interacting 
molecular species is low and sensitivity is poor. In comparison, an incredible amount of 
chemical, biological and medical information can be uncovered by single-molecule 
investigations [2]–[4].  
The variety of techniques available to measure molecular forces, structure, electronic states 
and interactions with other molecules is astonishing. The most versatile and the least 
perturbing methods are light-based. For instance, fluorescence in all its flavors dominates in 
vivo cellular studies revealing the mechanisms of protein-protein interactions, molecular 
motors, and all sorts of dynamic behaviors [5], [6]. Optical forces can also be used to trap and 
manipulate nano-objects, including molecules [7], [8]. Single-molecule sensitivity is the 
ultimate goal in clinical applications such as the detection and quantification of disease 
markers and novel drug screening methods [9]–[11]. 
In the past two decades many advances have been made to further the development of high 
resolution sensing schemes and the understanding of microscopic molecular behavior, 
however it is still rather uncommon to see single-molecule assay platforms in large-scale use. 
This is mainly due to the obstacles of parallelization and set-up robustness. On the way to 
finding new technological solutions, plasmonic sensing is seen as one of the strongest 
candidates for achieving multiplexed single-molecule real-time and label-free detection. To 
this day, we have the proof of some of the above-mentioned features, though not all at once in 
a single set-up. However, several questions still remain unanswered, leaving room for 
optimization and new ideas.  
At the same time medical and biological research has been uncovering interesting and 
promising functions of sub-micron-sized particles shed by cells and called extracellular 
vesicles, with particular emphasis on one type called exosomes. In addition and as a 
complement to their biological characterization, the physico-chemical properties of native 
vesicles are of great importance to the study of cellular communication in normal and disease 
states. Such knowledge can also be used for the development of artificial vesicles that can 
interact in an effective and tailored fashion with the intended recipient cells.  
Here multiple disciplines intersect to explore the complexity of biological material and the 
system-wide effects that unknown amounts of these tiny heterogeneous entities have on the 
whole living organism.  
One prominent example of the role of extracellular vesicles in cellular communication is 
the case of cancer. Tumor cells have been found to release greater amounts of extracellular 
vesicles than their normal counterpart and therefore are well-suited to produce and 
characterize these vesicles in vitro. 
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In this thesis work I have combined physical and biological research.  
In Ch. 2 I attempt to give an overview of the basic biology of one type of cancer cells and 
what extracellular vesicles are.  
I illustrate in Ch. 3 the basics of cellular stress models of cancer and how extracellular 
vesicles play a role in “informing” the environment about the changes that cells may undergo 
locally in response to a stress stimulus. Also, initial experiments to detect cellular stress in our 
model system are reported. 
Ch. 4 outlines general aspects of surface-based sensing, including the sources of noise and 
uncertainty in few molecule measurements.  
Ch. 5 summarizes the basics of plasmonic sensing, focusing on two distinct aspects, 
namely the inhomogeneous character of local sensitivity on the surface of a nanoresonator, 
and the power of dual-wavelength surface plasmon resonance sensing (SPR) to provide more 
information with higher accuracy on the determination of important and parameters in the 
biomolecular detection of lipid vesicles with emphasis on the complex and biologically 
relevant exosomes.  
Ch. 6 provides a basic description of stochastic diffusion-controlled reaction simulations, 
together with a summary of our results from in silico experiments.  
Ch. 7 describes -omic approaches to profile and quantify the content of cells and 
extracellular vesicles in order to tease out commonalities and differences across cellular types 
and growth conditions.  
Ch. 8 provides a short summary of the results in the appended papers. 
Finally, future outlook and perspectives are offered in Ch. 9. 
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Chapter 2 
Glioblastoma cells and extracellular vesicles 	  
2.1 Glioblastoma 
Gliomas originate from glial cells and are the most common type of malignant brain tumors 
[12]. The most common type of glioma is in turn astrocytoma. Glioblastomas (GBM) are a 
high grade aggressive type of glioma, constitute 15% of all brain tumors and 60-75% of 
astrocytomas [13]. 
A GBM cell population, as that of many tumors is highly heterogeneous and comprises 
also the presence of cancer stem cells (CSCs). These cells constitute the self-renewal and 
proliferative potential of a tumor owing to their stem-like characteristics. Various hypothesis 
exist on their origin including the evolutionary theory of cancer [14]. The first finding of 
CSCs in gliomas was accompanied by observation that the stem-like properties of tumor cells 
may be epigenetically induced and that a defective response to stimuli may contribute to the 
pathology [15]. However, the exact causes of gliomas and GBM initiation are unknown. 	  
2.2 Primary cells vs. cell lines 
In our work we include two commercially available glioma cell lines and two newly isolated 
patient-derived cell lines.  
The commercial cell lines are HTB-14™ a.k.a. U-87-MG (I will refer to it as U87 in the 
following pages) and HTB-148™ a.k.a. H4, both purchased from ATCC®. U87 is considered 
a high-grade glioma and has been widely used in cancer studies. H4 is considered a low-grade 
neuroglioma and it is categorized as non-tumorigenic based on xenograft tests. It is hence 
seldom utilized in cancer research. The primary cells are CSCs recently derived from adult 
GBM patients [16].  
Besides having been derived in different ways, the cells used in our studies, by their own 
nature, also differ in the culture conditions being used. In fact, U87 and H4 cell lines are 
typically cultured in the presence of fetal bovine serum (FBS), while CSCs are grown in 
defined serum-free medium [17]. Advantages of commercial cell lines over primary cells 
include their availability, robust protocols and characterization data, and in principle, their use 
as reference model systems for reproducible investigations. However, a recent DNA analysis 
revealed that long-term passaged glioma cell lines differ genetically from the original tumor 
leading to characteristics that may spoil some of the conclusions from research findings over 
the years [18]. 	  
2.3 Extracellular vesicles 
Extracellular vesicles (EVs) are produced virtually by all cells and have an emerging role in 
understanding cellular communication. They are made of a double lipid bilayer and carry 
surface markers and a cargo rich in proteins and nucleic acids. EVs are secreted in the 
extracellular matrix and are found in all body fluids, such that they elicited hopes to develop 
novel diagnostic and prognostic targets. The complexity and heterogeneity of these tiny 
biological material is overwhelming. On one hand biomedical scientists are trying to assess 
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their origin, biological functionality, absorption and potency, while on the other their precise 
composition and quantification remain elusive.  
With paper III we offer a review into the worlds of standard and state-of-the-art techniques 
that are used or are emerging as important tools to physically characterize and quantify 
extracellular vesicles in general and exosomes in particular. The introduction and references 
therein provide a background in the discovery, categorization, biogenesis, composition and 
function of extracellular vesicles and exosomes. 
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Chapter 3 
Cellular stress 	  
3.1 GBM, stress and extracellular vesicles 
When solid tumors grow they usually create a dense mass of cancer cells void of blood 
vessels, which creates a hypoxic core, i.e. a region hence with less access to nutrients and 
oxygen. During radiotherapy on the other hand free radical species are formed, which lead to 
cell damage and ultimately cell death via oxidative stress pathways. Both types of stressors, 
hypoxia and oxidative stress lead to cellular responses with significant changes in gene 
expression and cell physiology. 
Several studies have characterized exosomes from tumor cells of various origin[19], [20], 
how these vesicles are involved in cellular communication and pathology progression, how 
their protein and genetic content changes in response to a stimuli and how their differential 
composition upon stress impacts the effect on host cells in vitro or in vivo. 
Exosomes isolated from murine brain tumors revealed their immunological role beyond the 
blood brain barrier [21]. EVs from the U87 cell line have been characterized in the context of 
hypoxic stress and their role in angiogenesis in particular and tumor progression in general 
has been documented. Angiogenic tests, which model particular aspects of blood vessel 
formation, with U87-derived and other cancer-derived EVs are normally conducted in vitro 
using human umbilical vein endothelial cells (HUVECs) as a model system. Based on tube 
formation or migration capacity of these endothelial cells, exosomes from U87 under hypoxia 
were shown to contain elevated levels of angiogenic proteins and mRNAs [22]–[24], which 
identified extracellular vesicles released by cancer cells under hypoxia as mediator of tumor-
induced angiogenesis. The effects of ionizing radiation on the protein composition of EVs has 
also been reported for head and neck squamous cell carcinoma [25] and in breast cancer cells 
that show hypoxia-induced resistance to treatment [26]. Moreover, cells in hypoxic cores are 
found to be therapy resistant. Hence hypoxia related extracellular signaling mediated by 
exosomes is likely to persist after radiation induced damage. 	  
3.2 Hypoxia 
When oxygen levels decrease in a cell the hypoxia inducible factor 1 alpha (HIF1a) [27], [28] 
accumulates and translocates to the nucleus where it binds to HIF1b and activates the 
transcriptions of several genes involved in general cell adaptation, such as stress response, 
energy metabolism, and a specific hypoxia response, such as the expression and release of 
angiogenic proteins.  
Normal atmospheric oxygen levels present in cell culture systems correspond to around 
18%, which is very high compared to tissue O2 concentration in vivo. In the brain this level is 
even lower estimated at around 2-3% [29]. However, cells are adapted and considered to be in 
their normal growth conditions when cultured in standard incubators at 37˚C, 80% humidity, 
5% CO2 and 18-20% O2. 
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Figure 1 Schematic diagram illustrating the regulation of HIF-1α. Under normoxic conditions, prolyl 
hydroxylase domain (PHD) proteins use molecular oxygen as a substrate to hydroxylate HIF-1α. Once 
hydroxylated, HIF-1α binds the von Hippel-Lindau (VHL) protein and becomes polyubiquitylated (Ub) and 
targeted for proteosomal degradation. Under hypoxic conditions, PHD activity is reduced and HIF-1α escapes 
hydroxylation, accumulates and translocates to the nucleus where it binds with HIF-1β and CBP/p300 at the 
hypoxia response element (HRE). Reproduction from [30] 
  
3.2.1 Experimental conditions   
Hypoxic conditions in vitro are obtained using special incubators, which allow to flush 
nitrogen until a desired O2 concentration is reached, while keeping CO2 levels stable. Since 
the hydroxylation of HIF1a is both oxygen and iron dependent, hypoxia can be mimicked 
chemically by the administration of an iron chelator, which inhibits the function of PHD 
hence it leads to the accumulation of HIF1a.  
H4 and U87 cell lines were seeded, low sub-confluency was reached after 48h, at which 
point they received fresh culture medium for the beginning of the experiment and were placed 
in a hypoxia incubator at 1% O2 and 5% CO2 at 37ºC for 4 and 24 hours. In a separate 
experiment, hypoxia was mimicked by the administration of different concentrations of DIP – 
an iron chelator commonly used as a proxy for hypoxia – at the 48h medium change. In this 
case cells were collected at 0.5, 1, 2, 4, 8, 24 hours. 	  
3.2.2 ELISA detection of HIF1α   
We tested the induction of hypoxic conditions by assessment of the level of HIF1a with an 
ELISA kit (Human/Mouse Total HIF-1α; R&D Systems, Inc., Minneapolis, MN, USA). U87 
and H4 were seeded, after 48 hours standard medium or with the addition of various 
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concentrations of DIP was exchanged and cells were collected at several time points. In a later 
experiment, we tested the accumulation of HIF1a in a hypoxic chamber with 1% O2.  
 
Figure 2 HIF1a ELISA after 0.5, 1, 2, 4, 8, and 24 hrs after administration of different concentrations of DIP or 
after 24 hrs of incubation in the hypoxia chamber, from cellular extracts from U87 (left) and H4 (right) cells. 
The y-axis represents the ratio of HIF1a in the treated vs. a single untreated at 24hrs.	  	  
Our results (Fig. 2) confirm DIP as a potent inducer of HIF1a. H4 cells are more sensitive 
to DIP than the U87 cells. Both cell lines respond strongly in few hours from treatment and 
start dying at higher doses (not shown). Hypoxia treatment with actual oxygen deprivation 
induces similar levels of HIF1a as the highest non-lethal dose of DIP.  	  
3.3 Oxidative stress 
Oxidative stress may have various causes but primarily manifests itself with the accumulation 
of reactive oxygen species and free radicals which lead to DNA damage, protein adducts and 
lipid peroxidation[31], [32]. Ionizing radiation recapitulates many aspects of oxidative stress 
[25]. Hence, oxidative stress models are relevant in the study of cancer. 
As mentioned, one result of oxidative stress is the process lipid peroxidation that consists 
the degradation of lipids in the plasma membrane and other organelles. One byproduct of the 
degradation of arachidonic acid is a type of prostaglandin called 8-iso-PGF2alpha (PGF2a for 
shorts in this thesis) and it is used as a marker of non-canonical (non-enzymatic) lipid 
peroxidation induced by oxidative stress [33], [34].  
 
3.3.1 Experimental conditions   
All cell lines were seeded at an appropriate cell density in order to obtain low sub-confluency 
cultures after 48h, at which point they received fresh culture medium in order to begin the 
experiment. Oxidative stress was elicited by administration of tert-Butyl hydroperoxide 
(tBHP) [35] in a concentration of 20 µM for BAC-D0 cells, 30 µM for BAC-E3 and H4 cells, 
50 µM for U87 cells. The concentration was chosen in such a way to minimize cell death (less 
than 20%) in order to avoid overabundance of debris in the supernatant. The cells growing in 
control or oxidative stress condition were placed back in the incubator and collected at 
different time points.  
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3.3.2 ELISA detection of PGF 2α   
Post-culture U87-MG and H4 cells, including medium for controls and oxidative stress are 
hydrolyzed with 10N NaOH, for 2hrs at 45oC (1:1 dilution for cells and 4:1 for medium). 
Neutralization of samples is done with 12,1N HCL (pH adjusted to 6-8). The rabbit 
polyclonal anti-8-iso-PGF2α in the kit is used for competitive binding of cellular 8-iso-PGF2α 
or 8-iso-PGF2α with an alkaline phosphatase (ALP) molecule covalently attached to it. After 
incubation at room temperature for 2hrs in a clear plate coated with goat anti-rabbit 
polyclonal antibody, the wells are washed and ALP made to react with its substrate, p-
nitrophenyl phosphate (pNpp) for 45mins. The reaction is stopped with tri-sodium water and 
read immediately in a spectrophotometer at a wavelength 405nm. The lower is the signal, the 
higher the concentration of cellular 8-iso-PGF2α. 
 
	  
Figure 3 PGF2a ELISA in cellular extracts of U87, BAC-D0, BAC-D3 and H4, after 24 hrs administration of 
tBHP. The y-axis represents the ratio of treated vs. untreated. The colors represent separate experiments. 
 
In our measurements we did not see a consistent increase of PGF2a in the treated vs. 
untreated samples, neither in cellular extracts (Fig. 3) nor in the supernatant from these cells 
(not shown). One major issue encountered in this test was the difficulty to account for volume 
changes during samples preparation. Moreover, we cannot be sure whether isoprostanes are 
retained in the cells, or if they accumulate in the medium, and if so, how fast they degrade. 
Overall we conclude that the concentration of PGF2a in our samples was not consistently 
above the limit of detection of the ELISA kit.  
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Chapter 4 
Biosensing 	  
4.1 Biosensors 
A biosensor is a tool that detects the presence, and possibly also the amount of a biologically 
relevant substance, here referred to as the analyte. It does so by utilizing biochemical 
elements to interact with the analyte, and by transducing, that is by converting the information 
accessible by such interaction into a practically measurable (usually electronically) physical 
quantity that is the sensitive property of the sensor. This quantity can be, for instance, the 
force exerted on a micro-cantilever [36] upon contact with a micro or nano-scale object, or the 
change in the electrical conductance of nanowires [37], [38] due to changes in the 
environment, e.g. the introduction of a gaseous substance or the attachment of molecules. In 
general, one prefers label-free techniques, i.e. methods that can detect the analyte in its native 
state without the need to introduce e.g. a fluorescent label on the target. Each sensor type 
offers advantages and disadvantages and may be more or less suitable for a specific 
application. Light provides several transduction mechanisms as made evident by a great 
variety of optical biosensor techniques [39]–[43]. 
 
4.2 Surface-based biomolecular sensing 
In this thesis focus was put on surface-based biomolecular sensors, in which the biomolecular 
interaction happens on a fixed surface properly designed to provide the physical mean of 
transduction and the biochemical elements required to attract the analyte of interest. In real 
samples, i.e. complex mixtures such as blood, one must normally also suppress nonspecific 
binding of interfering molecular species. Surface-based sensors are often label-free which 
makes them simple assay platforms and it gives the opportunity to access raw information on 
e.g. the kinetics of the receptor-analyte interaction. 
Most of the concepts illustrated in this work are of general validity for all nanosensors, as 
will be explained later. However, specific examples from the area of plasmonic sensing will 
be used, since this work originated from the effort of optimizing plasmonic phenomena for 
sensing and bioanalytical applications. 
 
4.2.1 Reaction vs. diffusion-limited regime 
In a surface-based biosensor the sensitive surface is typically exposed to a liquid volume 
containing the analyte (label-free sensing). The final outcome of such biomolecular reactions 
is represented by the surface coverage, i.e. the amount of analyte bound to a given area of the 
sensor’s surface. The amount of analyte bound after a certain time depends on the initial 
concentration of the analyte in the solution and on the kinetic parameters characterizing the 
reaction between the analyte and its receptor molecules in a manner typically described by the 
Langmuir isotherm:                                                                                                     𝑑Γ𝑑𝑡 = 𝑘!"𝑐! Γ!"# − Γ 𝑡 − 𝑘!""Γ 𝑡                                                                           (  1  ) 
10	  	  
Here Γ(t) is the time-dependent surface coverage, Γ!"# is the maximum surface coverage 
achievable on the sensor, kon the binding rate constant (M-1s-1) and koff the unbinding rate 
constant (s-1). The concentration at the surface is c0 (the unit used for concentration defines 
the unit for Γ). When there are as many molecules leaving the sensor as there are attaching to 
it on average, an equilibrium condition is achieved and the equilibrium surface coverage Γ!" 
can be estimated by setting the temporal derivatives to zero:                                                                                                                                 Γ!" = Γ!"#𝐾! 𝑐! + 1                                                                                                                           (  2  ) 
where 𝐾!= koff / kon is the dissociation constant. 
The previous description (eq. 1 and 2) is valid in the so-called reaction limited regime, an 
approximation in which diffusion does not play a role in determining the local concentration 
of molecules at the surface available for binding. This is normally the case when the number 
of analyte molecules close to the sensor is relatively high compared to the number of 
available receptors. Usually this approximation is only valid after a certain waiting time, since 
initially, when all receptors are free, a depletion zone – a local volume near the surface with 
no or much less molecules than in bulk – is created as a consequence of the initial binding. 
On the other hand, when concentrations are very low compared to the receptors’ 
availability, and when the affinity is high, the surface coverage can become diffusion or mass- 
transport limited. Diffusion is macroscopically described by Fick’s first and second laws: 
                                                                                                                                                 𝑱 = −𝐷  ∇𝐶                                                                                                                          (  3− a  )                                                                                                                                             𝜕𝐶𝜕𝑡 = 𝐷  ∇!𝐶                                                                                                                          (3− b  )  
D is the diffusion constant, C is the concentration of the diffusing species, J is the flux 
density and it is generally a function of space and time. 
The time-dependent surface coverage for an infinite planar surface in contact with an 
infinite liquid with bulk concentration 𝑐 is found by solving Fick’s equations with the proper 
boundary conditions [44]. The solution is given by:                                                                                                                               Γ 𝑡 = 2𝑐 𝐷𝑡𝜋                                                                                                                                       (  4  )
Eq. 4 tells us that for infinitely high affinity (koff = 0), after a long 
enough time all the receptors will be occupied. In practice, the temporal evolution and the 
equilibrium value of the surface coverage depend on the interplay between diffusion and 
reaction.  
The system can then be modeled by coupling the Langmuir isotherm (Eq. 1) with Fick’s 
second law (Eq. 3-b). There is no analytical solution to this problem. Finite element methods 
can be used to obtain both a steady state and a time-dependent solution. The dimensionless 
Dahmköhler number has been suggested as a means to determine whether a system exhibits 
mass transport or reaction limited binding kinetics [45]. 
 
4.2.2 Geometrical aspects of diffusion 
It is important to notice that the full diffusion problem includes a 3D spatial dependence of 
the concentration. The spatial dependence disappears on the sensor surface when calculating 
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the surface coverage for symmetric situations such as the case of a planar surface, spherical 
sensor in a volume or hemispherical sensor on a flat substrate. Other than these cases, the 
presence of molecules on the sensor’s surface presents a non-uniform distribution that 
depends on the geometry of the sensor itself.  
This can be intuitively understood by considering a comparison between a hemispherical 
sensor and a disk-like sensor, placed on a flat substrate (Figure 1). Let us recall Fick’s first 
law (eq. 3 a) and assume C to be finite far away from the sensor and C=0 at the sensor 
surface. For the sake of clarity, in this example let us assume that the sensor is a perfect 
absorber and at all times C=0 at its surface. Let the molecules diffuse. The angular 
distribution of the flux around the hemisphere will be uniform due to symmetry and the 
probability to capture a molecule is equal for any point of the hemispherical surface. Now 
imagine squeezing the hemisphere against the substrate, making it more disk-like. What 
happens to the flux lines? The concentration and its gradient for this geometry are not uniform 
over the sensor surface due to a loss of symmetry. Therefore the flux lines will “adjust” to the 
new gradient by becoming denser at the edges than at the center of the flattened hemisphere. 
Consequently, the probability of capturing molecules is not uniform over the surface of a disk, 
and becomes higher the closer you are to the circumference.  
 
 
Figure 4 Illustration of the diffusion flux lines for a hemispherical absorber (left) and a flat disk-like absorber 
(right). The flux lines are homogeneous for the hemisphere, and inhomogeneous for the disk geometry. 
Fig. 4 illustrates the former example.  The analytical solution for the steady-state flux to a 
completely flat disk is given by [46]:                                                                                                                𝑗 𝑟 = 2𝐷𝑁!𝑐!𝜋 𝑎! − 𝑟!           ,        𝑟 < 𝑎                                                                                                      (  5  ) 
where 𝑁! is the Avogadro number, 𝑐! is the initial solution concentration (assumed to be 
constant everywhere in the solution) and a is the radius of the disk. From Eq. 5 it can be seen 
how the flux is significantly higher as r approaches the edge. 
For more complex structures it can be said that usually corners and edges will be exposed 
to denser flux lines than concave regions of the sensor or convex surfaces with small 
curvature. The geometry dependence of capturing probability is discussed in Paper II, where 
we look at the site-dependent binding probability obtained for various sensor shapes from 
stochastic simulations. 
 
4.3 Estimating vs. counting 
As the sensitivity and limit of detection are constantly being improved, incredibly small 
concentrations in the sub-picomolar range are being detected [47]–[50]. To give an idea, 1 fM 
corresponds to approximately 600 molecules per cubic millimeter, while a nanosensor with a 
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diameter of 100 nm (10000 times smaller than 1 mm) can be covered by about 300 receptor 
molecules. To put it bluntly, this means that for small sensors the number of molecules in a 
thin layer in the vicinity of the receptors is zero at almost all times, although the concentration 
is finite, and some of the time it is 1 or at the most 2. Under these conditions the concept of 
concentration itself breaks down and the equations for a continuous model illustrated above 
loose the validity and accuracy that they provide in macroscopic descriptions. They can only 
provide an average description of a system, but each individual experiment will likely deviate 
strongly from this result simply by chance. 
To understand the fluctuations in the system due to the individual molecules, one must 
adopt stochastic descriptions and numerical simulations of stochastic events instead of 
continuum models. Diffusion is easily modeled by discretizing either time or space, and 
calculating respectively either diffusive jumps or time intervals between jumps of pre-
determined length, according to probabilities which accurately describe diffusion processes. 
The incorporation of chemical interactions into such models is more challenging, mainly due 
to the problematic translation of the reaction constants into temporal and spatial parameters at 
the single molecule level. At this scale, in fact, a description based on molecular dynamics 
and energy potentials would be appropriate, but computationally and theoretically very 
demanding. However, several algorithms exist to simulate stochastic diffusion-reaction 
processes. In Chapter 5 we will briefly describe some basic aspects of this type of simulations 
and the implementation for our single-molecule noise study. 
 
4.4 End-point vs. real-time detection 
Current commercially available sensing tools are based on ensemble averaging over either 
large (active spot size of several mm) uniform areas – such as SPR [51] and quartz crystal 
microbalance (QCM) [52] – or large collections of sensing nanoentities [53], [54]. The 
sensing schemes can then be categorized into end-point and real-time detection. In an end-
point assay, such as the enzyme linked immunosorbent assay (ELISA) [55], after a certain 
number of reactions have taken place in order to capture the analyte onto the sensor’s surface, 
the only information accessible is the final surface coverage, which can be related to the 
original concentration in solution upon prior calibration of the device. In fact, even 
quantifying the surface coverage can be difficult and ELISA tests are normally used for 
yes/no diagnostic tests.  
In contrast, for real-time assays, the reaction utilized to bind the analyte is followed over 
time, until equilibrium is reached. Again, thanks to prior calibration, the signal produced by 
the equilibrium surface coverage is an indication of the concentration. However, the curve can 
also be fitted in order to extract reaction rate constants (kon and koff). It is also easier to verify 
that the system has actually reached equilibrium by looking at the binding curve.  
Increasingly faster and less noisy detectors represent an improvement in this direction. 
Higher acquisition speed and signal-to-noise ratio (SNR) allow performing fluctuation 
analysis [56], [57] by relying on the finer details of the signal. The latter approach was shown 
to provide more accurate estimation of the reaction rates than conventional curve fitting. 
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4.5 Single-molecule sensing vs. complex ensemble of nanoparticles 
As we have seen, considerable improvements in sensitivity and temporal resolution have led 
to the real-time detection of single-molecule events in some systems. On one hand ensemble 
average offers high accuracy due to the large number of events detected, on the other hand 
single molecule counting provides access to the understanding of molecular properties and 
interactions. For instance, it offers the possibility to determine reaction parameters in 
situations where few units of a certain biochemical species are present in clinical samples, as 
well as having the potential to discriminate between the competing reaction species binding to 
the same receptor(s). As D. R. Walt puts it, “counting molecules is as good as it gets” and 
optical detection methods have proven to provide the most accurate and less invasive tools for 
achieving this goal [6]. 
For example Mayer et al. [57] showed single-particle LSPR detection of single-molecule 
binding and unbinding events by analyzing sensitive signal fluctuations. Chen et al. [50] 
utilized amplified detection in a multiplexed end-point scheme and Poissonian fitting to relate 
the signal, produced by few molecular binding events to plasmonic nanosensors, to the 
concentration in solution. More recently, scientists have achieved single-particle single-
molecule sensitivity in real-time [58]–[61]. This is believed to be the ultimate sensing 
platform, albeit the present technological limits of reproducibility, parallelization, and cost. 
In the next section we discuss the need to gain deeper understanding in the origins of 
signal variation in situations when few molecules are being detected.  
Despite the advances of single-molecule sensing, certain fields need still to rely on 
ensemble measurements. The heterogeneity and biochemical complexity of extracellular 
vesicles makes them on one hand ideal candidates for interesting single-vesicle experiments, 
on the other it poses great limitations to the progress on their investigation. In fact, since 
physical sensing depends on several physical parameters that relate to the biomolecular 
nature, shape and size of vesicles [62], ensemble measurements are very important to assess a 
range for the determination of the concentration, an estimate deviation from the mean and its 
root causes. This type of problem is addressed further in section 2 of Ch.5 where we also 
discuss how careful ensemble measurements and theoretical modeling enabled the 
characterization of a sub-population of exosomes. 
 
4.6 Noise and uncertainty issues 
When measuring low signals or small changes in a signal, it is necessary to keep in mind what 
can affect the signal-to-noise ratio (SNR) of the measurement at the intensity being measured. 
Photodetectors are subject to several types of noise, briefly listed hereafter: dark noise, i.e. 
generation of thermal electrons (it can be reduced by cooling); read-out noise when measuring 
the charge of a pixel (it can be practically eliminated by amplification); background noise due 
to photons collected from other sources than the sample (it is convenient to measure in the 
dark); shot noise, stemming from the discrete nature of the measured signal (photon or 
electron flux). In contrast to the other noise sources, shot noise is not possible to eliminate and 
it increases proportionally to the signal. In fact, it follows Poissonian statistics, hence the 
fluctuations in the signal are proportional to 𝑁, where N is the number of photons or 
electrons being detected.  
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This means that as the absolute signal level (N) increases, the relative contribution of all 
other noise sources is reduced and the noise is mainly due to shot noise. However, the change 
in intensity one aims to measure in the sensing experiment is normally proportional to N. For 
instance, a plasmonic nanoparticle could change its light scattering yield by 0.01% when a 
molecule attaches to it. Therefore, SNR ~ N/ 𝑁 ~ 𝑁 and the influence from shot noise is 
reduced at higher intensities. In other words, although the noise level in N increases, the 
change in N increases more.  On the other hand, when N is small, all noise sources matter and 
should be minimized. This includes also minimizing sources of signal instability, such as 
mechanical vibrations and thermal fluctuations. Moreover, in plasmonic sensing, accurate 
determination of the resonance wavelength requires careful data analysis [63], ranging from 
curve fitting to centroid determination, rather than simple observation of the maximum 
position of a noisy peak.  
It is possible to achieve shot noise-limited measurements when measuring on large areas 
[64] but practically impossible when measuring on single nanosensors due to the limited 
number of photons/electrons. Assuming one can exploit such an optimum system and apply 
the best data analysis techniques [65], a level of uncertainty remains in the quantitative 
characterization of signal changes originating from biomolecular interactions occurring at the 
sensor’s surface. Unless all molecular binding events are clearly observed one by one, 
translating e.g. the plasmonic spectrum change into number of molecules bound can be very 
challenging. 
First of all, the signal change produced by a molecule binding to a nanoresonator is not 
constant for all binding events. In addition to being dependent on the size of the molecule, it 
also depends on where on the nanosensor the molecule binds. In fact, most nanosensors show 
a spatial dependent sensitivity distribution [66]–[69], which leads to varying signal 
amplitudes, and an uncertainty [70] in quantifying the source of the signal change, e.g. surface 
coverage or exact number of molecules binding/unbinding. Moreover, in the few molecules 
limit, the poor statistics compared to the experimental noise add to the complicacy of making 
good use of the data. 
The local sensitivity of plasmonic resonators will be addressed in Ch. 5.5 and it is dealt 
with in detail in Paper I. In Paper II we consider such inhomogeneous sensitivity in 
conjunction with the influence of sensor geometry on the preferential binding locations and 
we discuss the implications for signal accuracy in ensemble measurements and clear 
observation of single-molecule binding/unbinding events.  
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Chapter 5 
Plasmon resonances 	  
5.1 Surface plasmon resonance (SPR) 
It is a known fact that the reason why metals are good conductors is because the outermost 
electrons in metal atoms are not bound; hence, electromagnetic fields can induce electron 
movement in an orderly fashion, generally referred to as current. These electrons are said to 
constitute a free-electron gas. At the interface between a dielectric and a conductor, they can 
interact with electromagnetic field oscillations, giving rise to collective excitations called 
surface plasmon polaritons (SPPs).  
The surface plasmon resonance (SPR) effect can be described in terms of the dispersion 
relation of the surface plasmons (Eq. 6). By solving Maxwell’s equations with the proper 
boundary conditions for two semi-infinite materials (metal and dielectric) [71], we find the 
plasmon wave vector:                                                                                                                 𝑘!"" 𝜔 = 𝜔𝑐! 𝜀! 𝜔 𝜀!𝜀! 𝜔 +𝜀!                                                                                                             (  6  ) 
where the dielectric response is characterized by the dielectric constant 𝜀!= nd2, nd is the 
refractive index and the metal properties are described by the complex dielectric function 𝜀m. 
To a first approximation the energy dependence of 𝜀m can be described by the Drude model 
[72]. However, this does not reproduce experimental data accurately at all frequencies, e.g. 
damping at high frequencies (blue light) in the case of gold. A better model is found by the 
introduction of a damping in the equation of motion of the electron, leading to a Lorentzian 
solution for 𝜀m. For sensing purposes, the most important message from Equation 6 is that the 
wave vector 𝑘!"" is greater than the light line in the adjacent dielectric medium when this is 
air (n = 1) or water (n = 1.33). Therefore, due to the requirement of conservation of 
momentum, the surface plasmons cannot be excited by simply shining light on a metal 
surface.  
	  
Figure 1 Representation of Kretschmann configuration for SPPs excitation. The light passes through a prism and 
hits the metal film at a high incident angle. The evanescent field is coupled into SPPs at the metal/environment 
interface. (Courtesy of T. Antosiewicz) 
One possibility to achieve SPR is to use a higher refractive index medium (hence higher 
wave number) on the opposite side of a finite film to couple light into a plasmon running at a 
gold/water interface. The SPR is then observed as a minimum in the reflected light signal. 
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This is achieved through the use of a glass prism (n = 1.5) and it is known as Kretschmann 
geometry [73], arguably the most common configuration for SPR based sensing (Figure 2). 
The changes in SPR signal can be related to changes in refractive index [74] and give 
relatively accurate quantitative information on analyte coverage due to the planar surface 
geometry (1D spatial sensitivity distribution). 
Surface plasmons are waves characterized by a propagation length along the interface and 
a decay length (or penetration depth) into the medium. The shorter the decay length of the 
exponentially decaying transverse field, the better he confinement is said to be. However, the 
propagation length is reduced (higher imaginary wave vector) since the field becomes more 
focused to the lossy metal (for an understanding of SPPs mode confinement the reader may 
refer to [71]). In terms of sensing, this means that what happens far (~100 nm) from the 
gold/water interface – a change in the refractive index in the bulk medium – produces a 
smaller effect on the SPR spectral position and line-shape, than the same change happening at 
the surface.  
 	  
5.2 SPR shift 
The shift in wavelength or angle of the SPR minimum in the intensity of reflected light due to 
a change in the refractive index of the medium in contact with the metal surface supporting 
the surface plasmons is referred to as the SPR response, R. For a film thickness df and 
refractive index nf in contact with a bulk medium of index nb, R can be expressed as[74]:                                                                                                             𝑅 = 𝑆 𝑛! − 𝑛! [1− exp −𝑑!𝛿 ]                                                                                      (  7  ) 
where 𝛿 is the decay length of the SPR evanescent field intensity and S is the sensitivity, 
usually expressed in SPR signal per change of bulk refractive index units.  
One can introduce a dimensionless factor φ to take into account the relationship between 𝛿 
and d:                                                                                                                 𝜑 𝑑!𝛿 = [1− exp −𝑑!𝛿 ] 𝛿𝑑!                                                                                           (  8  ) 
hence 𝜑 is close to unity for thin films of thickness df <<  𝛿.  
We can introduce the quantities vm as the integral volume of molecules forming a 
nanoparticle, c* as the concentration of molecules per unit volume. Additionally, if a film is 
made of a supported layer of nanoparticles, we call c the surface concentration of 
nanoparticles. It can be shown that:                                                                                                                                          𝑐∗ =   𝛥𝛤!𝑑! = 𝑛! − 𝑛!𝑑𝑛𝑑𝐶∗                                                                                                           (  9  ) 
where 𝛥𝛤! is commonly referred to as surface coverage and is equal to c* df , i.e. the number 
of molecules in a film per unit surface area, or c c* vm for a film made of nanoparticles, and 
dn/ 𝑑𝐶∗  is the derivative of the refractive index with respect to the bulk molecule 
concentration. The SPR shift in eq. 7 can be rewritten in a more general form:                                                                                                                                           𝑅 = 𝑆 𝑑𝑛𝑑𝐶∗ 𝑐𝑐∗𝑣! 𝜑𝛿                                                                                                     (  10  ) 
17	  	  
By rewriting the volume term in eq. 10 for the appropriate geometrical case (e.g. a film, a 
layer of spherical beads, or a layer of deformed or non-deformed vesicles) one can obtain an 
expression for the dimensionless factor 𝜑. In particular, for a layer of undeformed vesicles of 
radius r :                                                                                                                 𝜑 𝑟𝛿 = [1− exp − 2𝑟𝛿 ] 𝛿2𝑟                                                                                           (  11  ) 
which can be replaced by eq. 8 provided that the film thickness df is simply written as the 
general layer thickness d=2r. As long as r <  𝛿 , this expression for 𝜑 is nearly identical for 
spherical beads and undeformed vesicles.  
 
 
5.2.1 Dual wavelength SPR 
The simultaneous measurement of SPR shift at two different wavelengths allows for the 
simultaneous and more precise determination of both the size and – if binding is diffusion 
limited – the bulk concentration of nanoparticles. This section describes the physical basis for 
extracting this information. 
Various terms in the expression for the SPR shift for a homogeneous film, a layer of beads 
or vesicles, represent wavelength-dependent physical parameters, namely S, dn/𝑑𝐶∗, 𝛿 and 𝜑 𝑑  for any d/  𝛿 ratio. From eq. 10 it follows that:                                                                                                                       𝑅!!𝑅!! = 𝑆!!𝑆!! (𝑑𝑛/𝑑𝐶∗)!!(𝑑𝑛/𝑑𝐶∗)!! 𝜑!!𝜑!! 𝛿!!𝛿!!                                                                                         (  12  ) 
 
Size determination 
Therefore, if one knows the values of S, dn/𝑑𝐶∗, 𝛿 at two wavelengths 𝜆! , 𝜆! and the 
specific dependence of 𝜑 𝑑 , by measuring the change of SPR signal at these two 
wavelengths, the thickness 𝑑 of the layer that produced these shifts (or 2r for a layer of 
particles of radius r) can be determined by the ratio 𝑅!!/𝑅!!. For a thin film where d <<  𝛿 eq. 
12 further simplifies to:                                                                                                                           𝑅!!𝑅!! = 𝑆!!𝑆!! (𝑑𝑛/𝑑𝐶∗)!!(𝑑𝑛/𝑑𝐶∗)!! 𝛿!!𝛿!!                                                                                                 (  13  ) 
Hence one can measure the sensitivity at two wavelengths, obtain literature values of the 
wavelength and concentration dependence of the refractive index for a given substance that 
forms a thin film on the SPR substrate, measure the SPR shifts’ ratio upon thin film formation 
and use eq. 13 to calibrate a dual wavelength sensing experiment by finding the 𝛿!!/𝛿!! ratio.  
 
Bulk concentration determination 
Thereafter, in combination with eq. 12 and the specific form of 𝜑 (e.g. eq. 11) one can 
determine the radius of nanoparticles of size comparable to the decay length. 
Under diffusion-limited steady-state flow conditions, Fick’s equations 3-a,b solved with 
the boundary conditions for a rectangular channel yield the following solution [75] for the 
surface concentration:                                                                                                                                 𝑐(𝑡) = 𝐶𝜉 𝐷!𝑄 !/!𝑡                                                                                                          (  14  ) 
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where C is the bulk concentration of nanoparticles, D is the diffusion constant (inversely 
proportional to the particles size), 𝜉 is a geometrical constant related to the geometry of the 
flow cell, and Q is the volumetric flow rate. By substituting eq. 14 in eq. 10 one can 
determine the bulk concentration:                                                                                                                             𝐶 = 𝑅(𝑡)𝐴𝜉 𝐷!𝑄 !/!𝑡                                                                                                                             (  15  ) 
with 𝐴 = 𝑆 !"!!∗ 𝑐∗𝑣! !!  .  
 
5.2.2	  SPR	  measurements	  of	  exosomes	  	  
In addition to the accuracy issues described in Section 5.6, the determination of size and 
concentration of heterogeneous nanoparticles such as exosomes is subject to also other and 
more severe sources of uncertainty, some of which can be removed by complementary 
measures, including the advantageous dual-wavelength SPR sensing method.  
 
Deformation of vesicles upon binding 
Vesicles are non-rigid objects and can be subject to shape deformation upon binding. 
Rupert et al. [76] investigated this phenomenon in previous work and introduced a formalism 
to specifically account for vesicle deformation in the expression of 𝜑 and hence obtain a 
better estimate of the bulk concentration. However, in order to quantify the binding of 
particles of a size comparable to the SPR evanescent field decay length one must rely on 
knowledge of the thickness of the film forming on the substrate. The degree of deformation 
on the substrate cannot be deduced from the particle size in solution nor can it be determined 
with a single wavelength SPR measurement, but it can indeed, as described above, be 
estimated with high accuracy using dual-wavelength SPR sensing. 
 
Heterogeneous sample 
Artificial lipid vesicles and native exosomes can be dimensionally characterized by an 
average size, but a given sample displays a more or less broad size distribution. This aspect 
has also been addressed in previous work [76] by the introduction of an extended formalism 
to model the surface coverage of exosomes. 
As described in Ch. 3, these vesicles, are also very complex in their composition such that 
their categorization in sub-populations based on surface markers has become an important 
aspect of their characterization. However, when targeting for measurement a specific sub-
population in a complex exosomes samples, it can be that the mean physical characteristics of 
such population differ from the mean of the whole sample. 
 
In Paper IV dual-wavelength SPR measurements and an extended formalism for the SPR 
response to films, rigid beads, and both deformed and undeformed vesicles were combined 
with complementary techniques (NTA, fluorescent NTA and TEM) to obtain, with high 
accuracy, information on the size determination of exosomes, the degree of deformation upon 
binding of CD63 positive exosomes, and an estimate of their bulk concentration as a sub-
population of the total suspended exosomes that is better than what is attained with other 
methods so far used to quantify exosomes. 
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5.4 Localized surface plasmon resonance (LSPR) 
Collective electron excitations can be observed also in small metal objects. When the size of 
the object is smaller than the resonant wavelength, the electric field of incoming light can 
polarize the whole particle “almost at once”. In this case, we talk about localized surface 
plasmon resonance (LSPR) since the electrons, though free to oscillate, are not free to 
propagate beyond the particle’s boundaries. The polarizability describes how a nanoparticle 
behaves in interaction with incoming electromagnetic energy. The polarizability for a 
spherical isotropic object can be derived in the quasi-static approximation and is given by:                                                                                                             𝛼 𝜔 = 4𝜋𝜀!𝑟! 𝜀! 𝜔 − 𝜀!𝜀! 𝜔 + 2𝜀!                                                                                                   (  16  ) 
where r is the radius of the sphere, 𝜀 d is the dielectric constant of the surrounding medium and 𝜀! is the permittivity of free space. A resonance condition is obtained by setting to zero the 
denominator in Eq. 8, giving ℜ[𝜀!(𝜔)] = -  2𝜀!.  
For non-spherical objects the polarizability is a tensor and in general the resonant 
frequency of a metal nanoparticle depends on its material, volume, shape, and the refractive 
index of the surrounding medium. The polarization field of the nanoparticle adds to the 
electric field of the incoming light. At resonance the field generated by the particle is the 
strongest, so it is said that the field there is locally enhanced relative to the incident field.  The 
field, in a first approximation, decays away from the particle like the near-field term of a 
dipole, i.e. 1/d3 where d is the distance from the resonator.  
As previously mentioned for SPR sensing, the magnitude of the change in the response of 
a LSPR depends on the distance from the sensor. This can be expressed in terms of bulk 
sensitivity versus local sensitivity. Svedendahl et al. [77] compared experimentally the bulk 
and local sensitivity between SPR and LSPR refractometric sensing schemes. The study 
demonstrated comparable performance of LSPR and SPR in detecting local changes, e.g. 
molecular binding, thanks to the higher field confinement of metal nanostructures compared 
to the thin film counterpart, and despite the much higher bulk sensitivity of SPR. It is of 
practical importance to notice that for equal sensitivity one advantage of using nanoparticles 
rather than thin films is that light coupling is trivial and it does not require the use of a prism 
and bulky configuration. Both transmission and reflection measurements can easily be 
performed. Another advantage (at least for single molecule resolution) is that it is relatively 
simple to perform measurements on single nanoparticles, which represents a very 
miniaturized sensor. Chen et al. [50] demonstrated the capability of multiplexed end-point 
single particle dark-field spectroscopy in ELISA assay with ultra-sensitivity. Other recent 
works support the great potential of LSPR for single-molecule detection (see Ch. 4.5). 
In the following section I will focus on the sensitivity of a plasmonic nanoresonator, 
pointing out how the local sensitivity is inhomogeneous in the vicinity of the sensor’s surface. 
 
5.5 Dipolar coupling and LSPR shift 
The response to light of two objects in proximity of each other is not simply the superposition 
of the singular responses, but also the interaction between their individual responses should be 
taken into account. If their dimension is smaller than the wavelength of the incoming light, 
their response can be modeled by a dipole and their interaction can be considered in the 
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framework of the Couple Dipole Approximation (CDA) [78]. The electric dipole induced by 
light in one object, produces a polarization field that contributes to the total field which 
influences the neighboring object, and vice-versa. So the total induced dipole polarization for 
a molecule (1) and a metallic particle (2) can be written as:                                                                                                                              𝑃! = 𝛼! 𝐸! − 𝐴!"𝑃!                                                                                                     (  17− a  )                                                                                                                             𝑃! = 𝛼! 𝐸! − 𝐴!"𝑃!                                                                                                     (  17− b  ) 
where 𝐸! is the incident field, 𝛼! and 𝛼! are the polarizability tensors of the two objects, and 𝐴!" = 𝐴!" = 𝐴 is the dipole mutual coupling term, which is also a tensor depending on the 
relative position of the objects with respect to each other and the direction and polarization of 
the incoming field. For the sake of simplicity we consider here only spherical objects and we 
drop the vector notation in Equation 17-a,b. The polarizability for a spherical object is given 
by eq. 7, which in air becomes:                                                                                                                 𝛼! = 4𝜋𝜀!𝑟!! 𝜀! − 1𝜀! + 2 ,            𝑖 = 1, 2                                                                                      (  18  ) 
where 𝑟! is the radius of sphere i, and the dielectric function 𝜀! is in units of 𝜀!. 
By inserting P1 (Eq. 17-a) in the expression for P2 (Eq. 8-b) we obtain:                                                                                                                               𝑃! = 𝛼! 1− 𝛼!𝐴1− 𝛼!𝛼!𝐴! 𝐸!                                                                                                            (  19) 
Equation 19 describes the response of the interacting system. By setting the denominator to 
zero we can calculate the mode frequencies. Moreover we can extract an expression for the 
effective permittivity 𝜀! of the metal resonator with the molecule present:                                                                                                                                   𝜀! 𝜔! = − 2+ 𝑄1− 𝑄                                                                                                                     (  20) 
where 𝑄 ≜ (4𝜋𝜀!)!(𝑟!𝑟!)! !!!!!!!!𝐴! is a parameter that depends on the mutual coupling A, 
their radii and the permittivity of the dielectric 𝜀!. 
For Q = 0 (no coupling) in Eq. 11, 𝜀! 𝜔! = −2, which is the resonance condition 
obtained by minimizing the denominator of the polarizability of a single metal 
nanosphere (Eq. 7). It is possible to derive an expression for the relative resonance frequency 
shift ∆𝜔 upon introducing a molecule near the particle. Without showing the derivation, in the 
case of small coupling (Q<<1), using Drude’s dielectric function for 𝜀! and considering that 
in the near field the coupling term A between a metal sphere and a molecule on its surface is 
proportional to 1/4𝜋𝜀!𝑟!!, we can write the result:                                                                                                           ∆𝜔 ≜   𝜔! − 𝜔!𝜔! ~− 12𝑉!𝑉! 𝜀! − 1𝜀! + 2   𝑓                                                                                (  21  ) 
From this relation it is evident how the change in resonance frequency is proportional to the 
ratio between the volumes   𝑉!  of the molecule and 𝑉!  of the metal particle, on the 
polarizability of the analyte 𝜀!, and on a factor 𝑓 (stemming from the coupling term A), which, 
to a first approximation, is proportional to the square of the local field enhancement. 
For the purpose of this thesis it is important to remind the reader of the fact that the 
polarizability of the molecule results in a small though obviously non-negligible disturbance 
of the plasmon oscillations in the metal object. This means that the details of the molecule’s 
polarizability may be disregarded in most cases, except for those instances where the aim is to 
understand intrinsic properties of the molecule in interaction with light, and the coupling of 
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the oscillation is strong, for instance in the presence of a nanoantenna with resonant frequency 
close to the energy involved in molecular state transitions. Instead, the polarizability of the 
metal particle is dependent on its size and shape, and, as we said, its orientation with respect 
to the incoming electromagnetic field. Hence, the coupling term Q is highly dependent on the 
molecule’s position with respect to the resonator. An analytical expression exists for the 
polarizability of an ellipsoid. However, this is a tensor and it hampers the possibility to use 
the approach above to obtain meaningful expressions for the position-dependent resonance 
shift. For ellipsoids and more complex structures one has to recur to numerical methods. In 
Paper I we illustrate a method to calculate the resonance shifts based on the local field 
intensities of the different constituents of the interacting system and compare it to Finite 
Difference Time Domain (FDTD) simulations. 
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Chapter 6 
Simulations of single molecules binding to single 
particles 	  
6.1 Stochastic diffusion-controlled reactions 
As anticipated in Chapter 4, for most purposes it is rather simple to simulate diffusion, and in 
the case of planar surfaces analytical expression can be obtained (see eqs. 4 and 14). 
However, the inclusion of reaction is a tricky business and it has been challenging 
biomathematicians for over a century.  
Diffusion is a continuous process by which objects of various dimensions trace ballistic 
trajectories in the medium in which they find themselves [79]. At the macroscopic level, 
Fick’s laws describe diffusion in terms of continuous changes of concentration, while at the 
microscopic scale the trajectories of single diffusing objects are described by discrete jumps 
constituting a “random walk”.  
Smoluchowski first developed a theory for diffusion-controlled reactions [80] later revised 
by Collins and Kimball [81]. Gillespie laid the foundation for the stochastic simulation 
algorithm (SSA) [82] . This model was later developed and expanded by many, as well as 
new models being established [83]–[87] resulting in an acceleration of the simulation time, 
but most importantly improved spatial resolution and temporal accuracy. One example of the 
application of stochastic diffusion-controlled reaction modeling is the study of dynamic 
compartmental models for the realistic description of biological systems and their 
kinetics [88].  
In our simulations we model diffusion through a Wiener process [89] such that, given the 
diffusion constant D, the mean diffusion length in a time interval dt is equal to 𝑠 = 2𝐷𝑑𝑡 . 
	  
Figure 9 Schematic representation of the multi-time discretization stepping algorithm used in our simulation 
scheme. A box of volume V (side view) contains N molecules. The box has reflective boundaries. An absorber is 
located on one side (bottom). The molecules randomly diffuse at every time step dt. The time step has a different 
value in different regions, such that dt1 > dt2 > dt3. As a consequence the diffusive jumps far from the absorber 
are on average bigger than in the hemispherical volumes closer to the sensor. 
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At each time step the spatial shift in x, y, and z directions is calculated by multiplying s by a 
random number drawn from the normal (0,1) distribution. So the mean diffusion step in all 
directions is equal to zero, while the mean absolute value and the standard deviation in 3D are 
both equal to 6𝐷𝑑𝑡 [90].  A cubic volume V, with a nanosensor located on one side of the 
cube, is filled with a fixed number of molecules N such that N/V is the desired concentration. 
By using multi-time discretization steps it is possible to simulate very small concentrations, 
while keeping a statistically significant N. This means that molecules far from the nanosensor 
explore bigger volumes than molecules close to the sensor in the same simulation time. 
Attention must be paid to the choice of the time steps, such that the molecules diffusing in 
proximity of the nanosensor undergo jumps that are on average much smaller (in our 
model <10X) than the characteristic size of the sensor. Figure 9 offers an illustration of the 
simulation scheme. 
The sensor surface is discretized in fixed receptors locations. If any molecule is close to a 
binding receptor we evaluate the binding probability within the relevant time step, in this case 
dt3 (see Figure 9Figure ). Concurrently, in each time step the unbinding probability of already 
bound molecules is evaluated and if an unbinding attempt is successful, the molecule begins 
to diffuse from the next time step. The probability of binding 𝑃! to any receptor is given by 𝑃! = 1− exp − 𝑟!!"#"$%&!' 𝑑𝑡 , where 𝑟! =   𝑘!"/𝑉! , 𝑘!" being the binding rate, and 𝑉! the 
spherical reaction volume of radius 𝑟!   given by the distance between the molecule and the 
receptor [82], which is non-zero only if the receptor is free. The sum runs over all receptors 
whose distance from the molecule is less than a critical distance.  
Several sensor geometries and diffusion/reaction parameters are utilized. The model offers 
a platform for in silico single-molecule sensing experiments. In the following section the main 
results of Paper II are summarized, accompanied by future outlook on the use of the model 
hereby developed. 
 
6.2 Results 
The time evolution of binding/unbinding events on the sensor’s surface can now be simulated 
with single event resolution.  
The analysis of multiple such time-traces allowed us to track the position dependent 
binding probability for different sensor geometries. For instance, as it is expected, a receptor 
located on the tip of a cone will on average be occupied much more easily than at the base of 
such cone. This effect obviously fades away as a high equilibrium surface coverage is 
approached, due to modification of the sensor’s landscape as seen by the molecules diffusing 
nearby as a consequence of receptor’s occupation. However, the effect for low surface 
coverage (Γ< 15%) is non-negligible at equilibrium, as it can produce a difference in binding 
probability between two receptor locations of around 20%.   
We also used the model to study the effect of LSPR inhomogeneous sensitivity distribution 
on the uncertainty of the signal produced by molecular binding and unbinding events. For 
instance, it was shown that the standard deviation of the signal is higher for a nanodisk under 
polarized than unpolarized illumination. It should be noted that this approach is not at all 
limited to plasmonic sensing, since the sensitivity maps of any type of sensor can be plugged 
in for analysis.  
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Chapter 7 
Omics based characterization of EVs 	  
7.1 Proteomics 
The human genome contains approximately 20000 protein-coding genes [91]. Today the 
Uniprot Knowledgebase database for the human proteome contains over 70000 proteins 
including post-translational modifications [92], [93]. Proteins can be detected and studied in 
two principles ways: i) by immunodetection (i.e. using antibodies); ii) by mass-spectrometry.  
The use of antibodies for protein detection and quantification has been arguably the most 
common method so far and has enabled e.g. molecular microscopy to flourish and many 
discoveries to be made. However, several limitations and problems may be encountered when 
trying an antibody for the first time, or the same antibody for a new type of sample or when 
looking at the reproducibility of results across experiments or biological materials or labs 
[94]. Until all actors undertake broad conjunct efforts to improve the standardization of 
antibodies production and use, researchers can safely rely only on extensive in-house 
validation and detailed reporting [95]. Despite these shortcomings, antibody detection of 
exosomes is very popular as it allows assessing an exosome sample’s purity with respect to 
the cellular lysates by looking for an enriched amount of typical exosomal markers (e.g. 
CD63, CD81, CD9, TSG101, etc.) [96] and absence of potential contaminants such as 
organelles markers (e.g. calnexin, GM130, etc.) [97]. 
In our characterization we utilized a high-throughput quantitative protein profiling 
approach based on mass-spectrometry (MS). Briefly, aliquots containing 100 µg of each cell 
lysate (CL) sample and 30 µg of each EVs sample were digested with trypsin over night using 
the filter-aided sample preparation (FASP) method [98]. In order to reduce the sample 
complexity, each CL sample was run through a fractionation kit and eight fractions collected. 
The samples were then analyzed by liquid chromatography tandem mass spectrometry (LC-
MS/MS) [99] using two quantitative methods, namely a) tandem mass tags (TMT)-based LC-
MS/MS [100], and b) intensity-based absolute quantification (iBAQ) [101]. 
In summary, fractions were placed in an Easy-nLC 1000 nanoflow liquid chromatography 
system interfacing an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher Scientific) 
in which the sample is injected directly after LC separation. 
In the a) TMT based method, the samples were isotope-labelled and mixed prior elution in 
the nLC system. This allows performing quantitation of the same peptides present in each 
sample relative to the other samples, hence to obtain a relative quantitation of proteins after 
identification (Fig. 10). 
The b) method, iBAQ, allows scoring the abundance of each protein relative to one another 
within the same sample. It is considered a pseudo absolute quantitative proteomics approach 
as it provides an estimate of abundance based on the measured and theoretical intensities.  
By combining pseudo absolute intra-sample quantification with relative inter-sample 
quantification one can establish that some proteins are very (much or little) abundant in just 
one sample. This allows interpreting the differences (intensities ratios) better than by the 
TMT-based quantitation alone.  
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Figure 10 Schematic representation of multiplex proteomic quantitation. Samples are labeled with individual 
mass tags and then combined for LC-MS/MS analysis. Because the masses of all of the tags are the same, 
identical peptides from different samples co-elute and are analyzed by MS. After tag cleavage induced by higher 
energy collision dissociation (HCD) and another round of MS, the tags are used to quantitate relative peptide 
intensities, while the peptide fragment ions are sequenced for protein identification. (reproduced from 
https://www.thermofisher.com/se/en/home/life-science/protein-biology/protein-biology-learning-center/protein-
biology-resource-library/pierce-protein-methods/quantitative-proteomics.html)  
 
 
7.2 Lipidomics 
The exosomal lipidome is not as well-studied as the proteome or the transcriptome. This is 
due to two main reasons which apply generally to lipidomics research beyond the 
extracellular vesicles field: 1) the bigger scale and higher complexity of the world of lipids; 2) 
the long-held idea that biological functions and diseases could be explained to the greatest 
extent by decoding the information at the gene and protein levels and their mutual 
interactions. It is interesting to stress that the known number of biologically relevant lipids 
grew exponentially in the recent years, from a mere 1000 cellular lipids [102] to over 40000 
documented unique chemical structures in the LIPID MAPS database 
(www.lipidmaps.org/data/structure/index.html). Furthermore, in theory, it is estimated that 
there are approximately 180000 different lipid species [103]. Placing lipids in perspective, 
their multitude and diversity is overwhelming compared to the human proteome. The latter 
observations suggest lipids may play critical biological functions. The recently developed 
technologies, informatics tools and analysis pipelines aiming at dissecting lipid-protein 
interactions, lipid synthesis and the role of lipids in metabolic pathways in healthy and disease 
26	  	  
states further contribute to confirm this hypothesis by making it possible to study lipid-
membrane related processes in a more comprehensive manner, taking into account the 
simultaneous contribution of multiple components to biomolecular interactions [104]. As 
summarized further in this section, questions concerning exosomal lipids are slowly being 
addressed in the literature, not only in regard to the mere composition but also on the role of 
specific lipids and lipid-proteins interactions for the production and transfer of extracellular 
vesicles.  
Lipids have for long been analyzed using chromatography techniques, which normally 
rely on one or more of the following characteristics: polarity, mass, solubility, and affinity. 
However, even the most advanced separation techniques don’t allow a resolution beyond 
identification of different lipid classes. Mass spectrometry methods based on similar 
principles to those utilized in proteomics (see section 2.1) provide an alternative or can be 
used in combination with chromatography (e.g. high performance liquid chromatography 
mass spectrometry - HPLC-MS) and are essential nowadays for lipids profiling. Nonetheless, 
the high molecular heterogeneity of lipids is reflected in highly distributed and overlapping 
mass fingerprints, making identification and profiling a complex and massive task. Yet the 
field of lipidomics is expanding and technical improvements are slowly being achieved [105]. 
The few studies analyzing the lipid content of exosomes have shown that the levels of 
sphingomyelins, phosphatidylserines and phosphatidylinositols are increased compared to the 
cellular plasma membrane. Furthermore, phosphatidylcholines are less abundant [106]–[110]. 
While some studies have suggested that cholesterol is enriched in the exosomal membrane 
compared to the cellular membrane, [106], [108]–[110] others have reported no increase in 
the ratio between cholesterol and phospholipids in the exosomal membrane [107]. Generally 
speaking, the particular composition of the exosomal membrane is likely to reflect the 
biogenesis and affect uptake and interactions with cellular compartments. For instance, some 
showed that exosomes budding is triggered by ceramides and is not associated with the 
endosomal sorting complex required for transport (ESCRT) [111]; others found that inhibition 
of ceramide formation does not block exosomes secretion in PC-3 cells, while the raft-
associated proteins, glycosphingolipids and flotillins affect the composition of released 
exosomes [112]. In the case of mesenchymal stem cells, exosome biogenesis has been 
associated with the presence of lipid rafts as expected for vesicles of endocytic origin [113]. 
These pioneering studies illustrate the importance of lipidomic investigations and it is likely 
that progress in the field will provide further valuable insights into exosome functions. A 
clearer picture of exosomal lipid composition may also result in useful methods for the 
discrimination of exosomes versus other lipid vesicles [114]. 
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Chapter 8 
Summary of results 
 
In Paper I we illustrate a method to calculate the LSPR shifts of different nanosensor 
geometries. The method is based on the local field intensities of the different constituents of 
the interacting system. We show its accuracy in comparison to Finite Difference Time 
Domain (FDTD) simulations. Local sensitivity maps for various plasmonic sensors can be 
obtained.	  
 In Paper II we use stochastic diffusion-reaction simulations to analyze the site dependent 
binding probability of diffusing molecules for various sensor geometries. We also compare 
the effect of inhomogeneous sensitivity distributions. The results are used to discuss the 
implications of these geometrical effects on the accuracy of the signal both in ensemble 
measurements and single-molecule observations. This system can further be used to study 
reaction rates in a quantitative way. For instance, the simulation of stochastic binding traces 
could test the relation between the reaction rates as calculated in solution and as accessible by 
single-molecule studies on surface sensors. 
In Paper III an extensive review on the world of extracellular vesicles and exosomes is 
offered from the prospective of biophysical characterization. Methods for qualitative and 
quantitative analysis are illustrated with their advantages and limitations.  
In Paper IV an extended formalism for the SPR response to films, rigid beads, and both 
deformed and undeformed vesicles was used to interpret dual-wavelength SPR measurements. 
In combination with complementary techniques (NTA, fluorescent NTA and TEM) the size of 
vesicles and exosomes was determined with high accuracy together with the degree of 
deformation upon binding of CD63 positive exosomes. Moreover, a better estimate of their 
bulk concentration as a sub-population of the total suspended exosomes was achieved. 
In Paper V we characterized the content of EVs isolated from two commercial (U87 and 
H4) and two primary glioma lines. U87 and H4 were treated with either hypoxia or a 
chemical inducer of oxidative stress (tBHP), while the primary lines were treated only with 
tBHP. We performed quantitative proteomics, transcriptomics and lipidomics on EVs and 
total cell extracts in treated conditions versus control and also compare across cell types. We 
found that: i) the proteome changes due to stress after 24h are weak in CLs but relatively 
large in the EVs; ii) EVs are abundant in RNA-binding proteins; iii) the major differences 
among samples were attributable to the cell type rather than the types of stressor; iv) despite 
very similar proteome of the cell lysates and EVs from the primary cell lines with respect to 
the commercial lines, their response to oxidative stress in terms of EVs proteome was rather 
negatively correlated; v) the U87 cells and EVs were the least responsive in terms of protein 
and RNA changes; vi) the lipidome of U87 and H4 cells vs. exosomes is markedly different; 
vii) while the lipidome of cell extracts seemed to be noticeably cell-type dependent and 
somewhat affected by stress, the lipid composition of EVs across these variables was rather 
homogeneous and in contrast with the major proteomic changes.  
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Chapter 9 
Outlook 	  
Biophysical modeling and highly sensitive physical platforms such as dual wavelength SPR 
are great tools not only to optimize and push the limits of sensing when a sensor is highly 
heterogeneous, but also to enable the correct interpretation of ensemble measurements in 
advanced sensing experiments of complex biological samples. Further development of these 
biophysical approaches, coupled with better vesicle isolation procedures pave the way to 
more precise analysis and biological studies that are required to inform a fundamental 
understanding and shape a consensus in this field. Moreover, any advance in this direction 
may lead to clinically and commercially relevant detection schemes. 
Specifically, in the case of EVs from glioblastoma, we have shown how their content 
changes strongly in response to stress and this change is cell-type dependent, in ways that are 
not easily predictable from broad similarities across cellular types. Primary cell lines that are 
also cancer stem cells have a distinct proteome and their EV content is markedly different 
from that of commercial cell lines. Studies found out that the U87 cell line, which has been 
considered for long a standard in cancer research should be reconsidered as it may have 
become a very artificial line far from real glioblastoma. If one wants to understand cellular 
communication in cancer in response to stimuli, a high number of primary cell lines [115] 
may be needed in the same study in order to tease out specific predictable differences that 
may be used in diagnostics or therapy.  
One recurrent category of proteins in EV proteomics is that of RNA-binding proteins. 
These proteins may turn out to be an interesting target for further investigations in several 
directions. In fact, the function of RBPs in EV-mediated cellular communication is not clear. 
Some of these proteins appear, for instance, in DNA remodeling pathways, hence suggesting 
an epigenetic modification of the recipient cells that is yet to be explored. Also, deeper data-
mining analysis, for instance using RNA binding domains (RBDs) and their target binding 
sequences, coupled to new experiments in the field of RNA molecules processing and 
transport, may help finding an explanation on how various RNAs are produced, packaged into 
exosomes and unpackaged in recipient cells. Of great interest in this regard is the approach 
and results obtained by combining quantitative proteomics, miRNA transcriptomics and in 
vitro vesicles production leading for example to the identification of YBX1 as preferential 
binding protein of the microRNA mi-223 and responsible for its loading into vesicles in cells 
and in cell-free assays [116]. Omics-based profiling of EVs could also reveal long-range and 
systemic communication in the healthy and diseased human body. 
Physical measurements of EVs, in combination with biomolecular experiments, will 
additionally help shedding light on specific and general features. For instance, one study 
showed that heparanase stimulates the exosomal secretion of syntenin-1, syndecan and other 
exosomal markers, such as CD63, in a concentration-dependent manner. In contrast, 
exosomal CD9, CD81 and flotillin-1 were not affected [106]. In our dataset, we did not 
observe ALIX and syndecan, but we found all other markers mentioned (syntenin, CD63, 
CD9, CD81, CD82, flotillin). Vesicles from different cell lines can vary a lot in composition, 
but it is also plausible that some basic features are shared across a multitude of cell types of 
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origin. Hence, with methods and results presented in this thesis, one could design experiments 
to compare the size of different exosome batches and sub-populations. Further, by comparing 
for instance the same sub-populations derived from different cell types (e.g. by including the 
deformation and size distribution formalism in future dual-wavelength and other experiments) 
one might find out indicative information to answer, among others, questions on the 
composition and biogenesis of exosomes regardless of cell-type, or tease out important 
differences among EVs from the same cell type exposed to different stimuli. 
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